Categories AlphaGraphs, Earnings, Health Care

Key highlights from Abbott (ABT) Q3 2022 earnings results

Abbott (NYSE: ABT) reported third quarter 2022 earnings results today.

Sales decreased 4.7% year-over-year to $10.4 billion. On an organic basis, sales increased 1.3%.

Net earnings declined 31.7% to $1.4 billion while EPS fell 30.8% to $0.81. Adjusted EPS dropped 18% to $1.15.

For FY2022, Abbott expects adjusted EPS to be $5.17-5.23.

Prior performance

Abbott Laboratories Q2 2022 Earnings Infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top